AAAAAA

   
Results: 1-13 |
Results: 13
FUDR ALONE OR IN COMBINATION WITH SYSTEMIC CHEMOTHERAPY (CT) IN LIVERMETASTASES FROM COLORECTAL-CANCER (CRC) - PRELIMINARY-RESULTS OF A RANDOMIZED GISCAD-SITILO TRIAL
Authors: PANCERA G FIORENTINI GM TUMOLO S BARNI S CERAVOLO C CORTESI E DALLAVALLE G COMELLA P MASSIDDA B CIRILLO F ANDREONI B MONTINARI F ZAMPARELLI G LABIANCA R VAGLINI M LUPORINI G
Citation: G. Pancera et al., FUDR ALONE OR IN COMBINATION WITH SYSTEMIC CHEMOTHERAPY (CT) IN LIVERMETASTASES FROM COLORECTAL-CANCER (CRC) - PRELIMINARY-RESULTS OF A RANDOMIZED GISCAD-SITILO TRIAL, Annals of oncology, 9, 1998, pp. 158-158
TEGAFUR AND FOLINIC ACID - CHEMOTHERAPY FOR ADVANCED COLORECTAL-CANCER (ACC) IN PATIENTS AGED OVER 70 YEARS - PRELIMINARY-REPORT
Authors: FERRARI V BARNI S MANDALA M BOLLINA R MENEGALLI M MORO E PANCERA G BERETTA G REPETTO L
Citation: V. Ferrari et al., TEGAFUR AND FOLINIC ACID - CHEMOTHERAPY FOR ADVANCED COLORECTAL-CANCER (ACC) IN PATIENTS AGED OVER 70 YEARS - PRELIMINARY-REPORT, Annals of oncology, 9, 1998, pp. 67-67
INTENSIVE WEEKLY CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC-CANCER USING 5-FLUOROURACIL, CISPLATIN, EPIDOXORUBICIN, 6S-LEUCOVORIN, GLUTATHIONE AND FILGRASTIM - A REPORT FROM THE ITALIAN GROUP FOR THE STUDY OF DIGESTIVE-TRACT CANCER (GISCAD)
Authors: CASCINU S LABIANCA R GRAZIANO F PANCERA G BARNI S FRONTINI L LUPORINI G CELLERINO R CATALANO G
Citation: S. Cascinu et al., INTENSIVE WEEKLY CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC-CANCER USING 5-FLUOROURACIL, CISPLATIN, EPIDOXORUBICIN, 6S-LEUCOVORIN, GLUTATHIONE AND FILGRASTIM - A REPORT FROM THE ITALIAN GROUP FOR THE STUDY OF DIGESTIVE-TRACT CANCER (GISCAD), British Journal of Cancer, 78(3), 1998, pp. 390-393
HIGH-DOSE VERSUS LOW-DOSE LEVO-LEUCOVORIN AS A MODULATOR OF 5-FLUOROACIL IN ADVANCED COLORECTAL-CANCER - A GISCAD PHASE-III STUDY
Authors: LABIANCA R CASCINU S FRONTINI L BARNI S FIORENTINI G COMELLA G ZANIBONI A GOTTARDI O ARNOLDI E OLIANI C DURO M PAVANATO G MARTIGNONI G RAINA A PIAZZA E DALLAVALLE G VALSECCHI R PANCERA G LUPORINI G
Citation: R. Labianca et al., HIGH-DOSE VERSUS LOW-DOSE LEVO-LEUCOVORIN AS A MODULATOR OF 5-FLUOROACIL IN ADVANCED COLORECTAL-CANCER - A GISCAD PHASE-III STUDY, Annals of oncology, 8(2), 1997, pp. 169-174
INTENSIVE WEEKLY CHEMOTHERAPY FOR ADVANCED GASTRIC-CANCER USING FLUOROURACIL, CISPLATIN, EPI-DOXORUBICIN, 6S-LEUCOVORIN, GLUTATHIONE, AND FILGRASTIM - A REPORT FROM THE ITALIAN GROUP FOR THE STUDY OF DIGESTIVETRACT CANCER
Authors: CASCINU S LABIANCA R ALESSANDRONI P MARCELLINI M SILVA RR PANCERA G TESTA E MARTIGNONI G BARNI S FRONTINI L ZANIBONI A LUPORINI G CELLERINO R CATALANO G
Citation: S. Cascinu et al., INTENSIVE WEEKLY CHEMOTHERAPY FOR ADVANCED GASTRIC-CANCER USING FLUOROURACIL, CISPLATIN, EPI-DOXORUBICIN, 6S-LEUCOVORIN, GLUTATHIONE, AND FILGRASTIM - A REPORT FROM THE ITALIAN GROUP FOR THE STUDY OF DIGESTIVETRACT CANCER, Journal of clinical oncology, 15(11), 1997, pp. 3313-3319
FACTORS INFLUENCING RESPONSE RATES FOR ADVANCED COLORECTAL-CANCER CHEMOTHERAPY
Authors: LABIANCA R PANCERA G LUPORINI G
Citation: R. Labianca et al., FACTORS INFLUENCING RESPONSE RATES FOR ADVANCED COLORECTAL-CANCER CHEMOTHERAPY, Annals of oncology, 7(9), 1996, pp. 901-906
ORAL ETOPOSIDE AS 2ND-LINE CHEMOTHERAPY FOR COLORECTAL-CANCER - A GISCAD STUDY
Authors: ZANIBONI A LABIANCA R PANCERA G BARNI S FRONTINI L MARINI G LUPORINI G
Citation: A. Zaniboni et al., ORAL ETOPOSIDE AS 2ND-LINE CHEMOTHERAPY FOR COLORECTAL-CANCER - A GISCAD STUDY, Journal of chemotherapy, 7(3), 1995, pp. 246-248
L-LEUCOVORIN (LLV) AS A MODULATOR OF 5-DAYS 5-FLUOROURACIL (5FU) IN ADVANCED COLORECTAL-CANCER (ACC) - HIGH-DOSE (HD) VERSUS MW DOSE (LD)
Authors: LABIANCA R CASCINU S BARNI S FIORENTINI G FRONTINI L COMELLA G ZANIBONI A DALLAVALLE G PANCERA G LUPORINI AC PESSI A LUPORINI G
Citation: R. Labianca et al., L-LEUCOVORIN (LLV) AS A MODULATOR OF 5-DAYS 5-FLUOROURACIL (5FU) IN ADVANCED COLORECTAL-CANCER (ACC) - HIGH-DOSE (HD) VERSUS MW DOSE (LD), European journal of cancer, 31A, 1995, pp. 735-735
EFFICACY OF ADJUVANT FLUOROURACIL AND FOLINIC ACID IN COLON-CANCER
Authors: LABIANCA R MARSONI S PANCERA G TORRI V ZANIBONI A ERLICHMAN C PATER J SHEPHERD L ZEE B SEITZ JF MILAN C PIGNON JP AITINI E APOLONE G AUZZANI A BANDUCCI S BARNI S BERETTA GD BIFFI O BUCCI F CARDI G CIFATTE D COLUCCI G COMANDONE A COMELLA G CONFALONIERI C CONFU A COSTANZO M CRESPI C DAMIANI E DEGIORGI D DONGIOVANNI V FABRIS G FABRIZIO G FACENDOLA G FANTONI PA FERRAGNI A FIORI B FLORIANELLO F FRONTINI L GALLI E GARATTINI P GHERARDI G GIOVANELLI A GUILIANI F GOSSO P JANNIELLO GP KILDANI B LEO S LIBERATI A MAFFIONE G MAIELLO E MAIORINO L MANENTE P MARTIGNONI GC MARZOLA M MASTRODONATO M MERIGGI F MOLINARI B MOLINARI GF MONFERRONI N NASCIMBEN O NATALE C NEGRETTI S PALAZZO S PANVINI D PARISI V PEDICINI T PERADOTTO F PESSA S PIATTO E PIZZI G PROSPERI A PRUSCIANO F RABBI C RAINA A RUGGIERO A SAVA C SCANZI F CARRARO PS SMERIERI F STIVALA B TAIANA A TARDIO B TESTORE F TINAZZI A TURCATO G ZONATO S AYOUB J BELANGER K BIRON G BODURTHA AJ BOOS G BURNELL M CANO P CHARPENTIER D CHOW WSW CHRITCHLEY J CRIPPS C DANG SP DAVIS ML DAVIDSON M DINGLE B DRYER D FERLAND E FIELDS A FINE S JOLIVET J KAISER L KERR I KOCHA WI KOTWALL C KRIEGER H LEPINEMARTIN M LITTLE C LOFTERS WS MAHEU M MOORE M PRESSNAIL B RAGAZ J RAUNER H REZNICK R ROSS T ROTSTEIN L RUDINSKAS L SCHACTER B SHAH A SKILLINGS J STERN H TWEEDDALE M VANDENBERG T WALDE D WATT HJ WONG KWA YOSHIDA S BALDIT C BARONI JL BAZIN JP BEDENNE L BLANCHI A BOGNEL JC BOSSET JF BOUCHE O BRANDONE JM BRICOT R BURTIN P CADOR L CHARBIT M CHARLIER A COUROUBLE Y COUZIGOU P CUILLERET J DELPERO JR DUCREUX M DUMAS F ECHINARD E ETIENNE PL FRIGUET JL GIGNOUX M GIOVANNINI M HERR JP LAFON J LETREUT P LATRIVE JP LAUVAUX C LOUVET C MACKIEWICZ R MAUREL C MESSERSCHMITT C MORAND L MOREAU J MORIN T NORDLINGER B NOTERDAEME PM OLLIER JC PICAUD R PEINKOWSKI P PLACHOT JP PORTET R DUBATY HR ROUGIER P ROZENTAL G SASTRE B VOTTELAMBERT A WATRIN B ZEITOUN P
Citation: R. Labianca et al., EFFICACY OF ADJUVANT FLUOROURACIL AND FOLINIC ACID IN COLON-CANCER, Lancet, 345(8955), 1995, pp. 939-944
EPIRUBACIN, CISPLATIN, AND CONTINUOUS-INFUSION 5-FLUOROURACIL IS AN ACTIVE AND SAFE REGIMEN FOR PATIENTS WITH ADVANCED GASTRIC-CANCER - AN ITALIAN GROUP FOR THE STUDY OF DIGESTIVE-TRACT CANCER (GISCAD) REPORT
Authors: ZANIBONI A BARNI S LABIANCA R MARINI G PANCERA G GIACCON G PIAZZA E SIGNAROLDI A LEGNANI W LUPORINI G
Citation: A. Zaniboni et al., EPIRUBACIN, CISPLATIN, AND CONTINUOUS-INFUSION 5-FLUOROURACIL IS AN ACTIVE AND SAFE REGIMEN FOR PATIENTS WITH ADVANCED GASTRIC-CANCER - AN ITALIAN GROUP FOR THE STUDY OF DIGESTIVE-TRACT CANCER (GISCAD) REPORT, Cancer, 76(10), 1995, pp. 1694-1699
PHASE-II TRIAL OF 5-FLUOROURACIL AND THE NATURAL 1-ISOMER OF FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL-CARCINOMA
Authors: ROSSO R MAZZEI T SOBRERO A MINI E CARTEI G CONTE P LABIANCA R CARTEI F FALCONE A PANCERA G BARSANTI G DICOSTANZO F GUGLIELMI A BOLLI E TIXI L ASCHELE C RIBECCO A PERITI P
Citation: R. Rosso et al., PHASE-II TRIAL OF 5-FLUOROURACIL AND THE NATURAL 1-ISOMER OF FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL-CARCINOMA, European journal of cancer, 30A(3), 1994, pp. 338-343
DOUBLE-MODULATION OF 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER WITH LOW-DOSE INTERFERON-ALPHA-2B AND FOLINIC ACID - THE GISCAD EXPERIENCE
Authors: LABIANCA R GIACCON G BARNI S AMBROSINI G IIRILLO A FIORENTINI G DURO M PIAZZA E OLIANI C PANCERA G CASCINU S MARTIGNONI G ZANIBONI A DALLAVALLE G LUPORINI G
Citation: R. Labianca et al., DOUBLE-MODULATION OF 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER WITH LOW-DOSE INTERFERON-ALPHA-2B AND FOLINIC ACID - THE GISCAD EXPERIENCE, European journal of cancer, 30A(11), 1994, pp. 1611-1616
MEDICAL-TREATMENT OF HEPATOCELLULAR-CARCINOMA
Authors: LUPORINI G LABIANCA R PANCERA G
Citation: G. Luporini et al., MEDICAL-TREATMENT OF HEPATOCELLULAR-CARCINOMA, Journal of surgical oncology, 1993, pp. 115-118
Risultati: 1-13 |